Process Validation Lifecycle

The 2011 FDA guidance replaced the old “three batches and you are validated” mindset with a lifecycle. Stage 1 (Process Design) builds process understanding — defining the critical quality attributes, identifying the critical process parameters that drive them, and establishing the design space, usually through development studies and risk assessment rather than full-scale runs.

Stage 2 (Process Qualification) proves the commercial process works. It has two parts that are often conflated: qualifying the facility, utilities, and equipment, and then the Process Performance Qualification itself — commercial-scale batches run under the commercial procedure by the people who will actually run it.

Stage 3 (Continued Process Verification) is the part most often under-resourced. It requires ongoing monitoring of the process in routine production to confirm it stays in a state of control — trending CPPs and CQAs, detecting drift, and feeding change control and CAPA. A process that passed PPQ two years ago and has never been trended since is not validated in the sense the guidance intends.

• —Stage 1 — Process Design: build understanding; define CQAs and the CPPs that control them.
• —Stage 2 — Process Qualification: qualify facility/utilities/equipment, then run PPQ at commercial scale.
• —Stage 3 — Continued Process Verification: trend the process in routine production and act on drift.
• —The number of PPQ batches is a science- and risk-based justification, not a fixed three.
• —Validation is a state you maintain, not a milestone you pass — Stage 3 is where most inspection findings land.

FDA, Process Validation: General Principles and Practices (January 2011); EU GMP Annex 15 (2015); ICH Q8(R2), Q9(R1), Q10, and Q11 for the underlying development, risk, and quality-system framework.